Connect with us

Technology

Sony Electronics Announces XYN Motion Studio App that Accelerates Creative Use of Motion Data

Published

2 weeks ago

on

Making full-fledged motion production accessible with improved accuracy, motion “tweening,” and auto-tagging functions

SAN DIEGO, Jan. 6, 2025 /PRNewswire/ — Sony Electronics Inc. (“Sony”) announced the launch of “XYN Motion Studio*1,” as the first product under Sony’s new brand “XYN™*2(/zin/),” which integrates software and hardware solutions for spatial content creation. XYN Motion Studio is a PC application which supports connections with 12 “mocopi®” sensors and utilizes Sony’s proprietary algorithms for automatic motion interpolation and auto-tagging functions, that enhances and streamlines the creative use of motion data.

The mobile motion capture system “mocopi” launched in 2023, uses Sony’s unique algorithms to achieve high-precision motion measurement with only six small and lightweight sensors connected to a smartphone app1. “mocopi” has been utilized not only by VTubers and Virtual Reality (VR) social platform users but also by creators in game, film, and animation production. The new XYN Motion Studio builds on the advantages of “mocopi,” such as studio- or suits-free motion capture, enhancing precision through connections with 12 sensors via dedicated sensor data receivers for direct connection with a PC (professional mode)*3. The application also adds new functions such as editing of motion data, making motion capture more accessible to a wider range of creators in various genres, who have previously faced high costs and equipment hurdles.

With the launch of XYN Motion Studio, Sony also offers bands for attaching additional sensors to both arms, thighs, and hands (or feet). Additionally, the existing “mocopi” PC application*4 will be updated to support direct connections between 12 “mocopi” sensors and a PC via the new receiver.

In addition to enhanced precision by professional mode, XYN Motion Studio also takes advantage of the proprietary algorithms used in “mocopi” to enable new features such as motion data editing, automatic motion interpolation that generates natural motion data connecting different motions, and automatic tagging of motion data uploaded to the cloud which enables text-based searching.

Sony aims to liberate creators in the spatial content production field to eliminate any hurdles of time constraints and location through technology.

Main Features

1. Easy and precise motion capture with professional mode (connection with 12 sensors)
Users can acquire more precise motion data by wearing 12 “mocopi” sensors to both arms, thighs, and hands (or feet) in addition to head, hip, ankles and wrists, which are directly connected to a PC with the XYN Motion Studio app installed, via the sensor data receivers*5.
The app also uses raw data from the sensors to improve grounding of the avatars’ feet, while the new ‘camera blending’ feature further enhances data accuracy by combining footage from a camera connected to the PC with data from the sensors.

2. Motion data editing made simple and efficient with automated features
XYN Motion Studio allows users to edit motion data recorded within the app, or other data in compatible formats. The app also features automatic motion interpolation (“tweening”) that smoothly connects two or more motions by generating natural and realistic motion data between them.
Furthermore, edited motion data can be used with various industry-standard digital content creation tools*6, enabling creators to integrate the tool flexibly into their own workflows.

3. Cloud and automatic tagging features*7 accelerate the utilization of motion data
By uploading motion data to the cloud, users can not only store their data for their convenience, but also  have the app automatically analyze and tag motion data using proprietary algorithms, which enables text-based search. Frequently used motion data is also provided as presets within the app, enhancing the convenience of motion data editing and utilization.

Pricing and availability 
XYN Motion Studio app will be available for Windows PCs. The app can be downloaded from Microsoft Store, starting end of March 2025. The use of the app requires Microsoft accounts.
The Sensor data receiver for “mocopi” and Sensor bands for “mocopi” will be available exclusively at www.electronics.sony.com.

Specifications/Resources
Full specifications are available at https://xyn.sony.net/en/products/xyn_motion_studio

“SONY” “Sony” and “mocopi” are trademarks or registered trademarks of Sony Group Corporation or its affiliates. Other product names, service names, logos and/or company names used in this Press Release are trademarks, registered trademarks or copyrighted properties of their respective owners.

About Sony Electronics Inc.  
Sony Electronics is a subsidiary of Sony Corporation of America and an affiliate of Sony Group Corporation, one of the most comprehensive entertainment companies in the world, with a portfolio that encompasses electronics, music, motion pictures, mobile, gaming, robotics and financial services. Headquartered in San Diego, California, Sony Electronics is a leader in electronics for the consumer and professional markets. Operations include research and development, engineering, sales, marketing, distribution and customer service. Sony Electronics creates products that innovate and inspire generations, such as the award-winning Alpha Interchangeable Lens Cameras and revolutionary high-resolution audio products. Sony is also a leading manufacturer of end-to-end solutions from 4K professional broadcast and A/V equipment to industry leading 4K and 8K Ultra HD TVs. Visit http://www.sony.com/news for more information. 

*1. XYN Motion Studio runs on Windows PCs.
*2. For the press release on “XYN” please see https://www.sony.net/corporate/information/news/202501/25-001E/
*3. Mobile motion capture system “mocopi” includes 6 sensors. Using professional mode requires 2 sets of “mocopi.”  
*4. For details about the “mocopi” PC application please see
https://www.sony.net/Products/mocopi-dev/en/documents/mocopiPC/HowTo_mocopiPC.html  
*5. The Sensor data receiver for “mocopi” supports connection with 6 “mocopi” sensors per device. 2 “mocopi” data receivers are requires to pair 12 “mocopi” sensors with the XYN Motion Studio app or the “mocopi” PC application.
*6. XYN Motion Studio supports BVH and FBX formats.
*7 XYN Motion Studio requires Microsoft account.
*The screen images shown are for illustration purposes only and may not be an exact representation of the final product.

1 Download app at Google Play and the App Store. Network services, content, and operating system and software subject to terms and conditions and may be changed, interrupted or discontinued at any time and may require fees, registration and credit card information. Use of third party services or apps may require registration and/or acceptance of a license agreement, privacy policy and other terms and conditions. Sony bears no responsibility for third party websites, services and apps. Features and specifications are subject to change without prior notice.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sony-electronics-announces-xyn-motion-studio-app-that-accelerates-creative-use-of-motion-data-302343513.html

SOURCE Sony Electronics, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

COHEN & STEERS REPORTS RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2024

Published

3 minutes ago

on

January 22, 2025

By

NEW YORK, Jan. 22, 2025 /PRNewswire/ — Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the fourth quarter and year ended December 31, 2024. The earnings release along with the accompanying earnings presentation can be viewed at Cohen & Steers Reports Results for Fourth Quarter and Year Ended December 31, 2024 and on the company’s website at www.cohenandsteers.com under “Company—Investor Relations—Earnings Archive.”

Conference Call

The company will host a conference call tomorrow, Thursday, January 23, 2025, at 10:00 a.m. (ET) to discuss these results via webcast and telephone. Hosting the call will be chief executive officer, Joseph Harvey, chief financial officer, Raja Dakkuri, and head of multi-asset solutions, Jeffrey Palma.

Investors and analysts can access the live conference call by dialing 800-715-9871 (U.S.) or +1-646-307-1963 (international); passcode: 8494569. Participants should plan to register at least 10 minutes before the conference call begins. A replay of the call will be available for two weeks starting approximately two hours after the conference call concludes and can be accessed at 800-770-2030 (U.S.) or +1-609-800-9909 (international); passcode: 8494569. Internet access to the webcast, which includes audio (listen-only), will be available on the company’s website at www.cohenandsteers.com under “Company—Investor Relations” under “Financials.” The webcast will be archived on the website for one month.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.

View original content:https://www.prnewswire.com/news-releases/cohen–steers-reports-results-for-fourth-quarter-and-year-ended-december-31-2024-302357884.html

SOURCE Cohen & Steers, Inc.

Continue Reading

Technology

Equifax Announces Earnings Release Date and Conference Call for Fourth Quarter 2024 Results

Published

3 minutes ago

on

January 22, 2025

By

ATLANTA, Jan. 22, 2025 /PRNewswire/ — Equifax® (NYSE: EFX) will announce its financial results for the fourth quarter ended December 31, 2024, in a release to be issued on Thursday, February 6, at 6:30 a.m. Eastern Time (ET).

Equifax will host a conference call at 8:30 a.m. ET on February 6, in which senior management will discuss financial and business results for the quarter. Related presentation materials will be published on investor.equifax.com on February 6 at 6:30 a.m. ET.

Conference Call:  
US/Canada: 877-559-1190 / +1 201-389-0916
International: Click here for participant International Toll-Free access numbers

Please dial the appropriate number 5-10 minutes prior to the call to complete registration. Name and affiliation/company are required to join the call.

Webcast:
To view the webcast and slide presentation, please click the link and enter your information to be connected. The link becomes active 15 minutes prior to the scheduled start time.

An audio replay of the conference call will be available on investor.equifax.com beginning on February 7.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Molly Clegg for Equifax
molly.clegg@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-earnings-release-date-and-conference-call-for-fourth-quarter-2024-results-302357665.html

SOURCE Equifax Inc.

Continue Reading

Technology

Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio, and Eleszto Genetika Announce Strategic Unification

Published

3 minutes ago

on

January 22, 2025

By

NORTON, Va., LA ROCHELLE, France and BUDAPEST, Hungary, Jan. 22, 2025 /PRNewswire/ — Today, SOLARBIOTECH, GPC Bio, and Eleszto Genetika proudly announced their acquisition and strategic unification under a single ownership. 

This consolidation creates a vertically integrated Synthetic Biology and Biomanufacturing powerhouse, uniquely positioned to harness the disruptive potential of precision fermentation. By integrating decades of expertise, the unified organization will leverage the strength of each team to seamlessly advance Synthetic Biology innovation from ideation to commercial production.

The acquisitions bring together over 100 engineers, scientists, and seasoned biotech executives, marking a significant leap forward in the rapidly evolving biomanufacturing landscape. The unified organization is fully equipped to give clients unparalleled and seamless support in all stages of biomanufacturing, including microbial strain and bioprocess development, plant engineering, automation, construction, deployment, and large-scale operations. The coming months will involve further integrational activities to fully leverage the strength of the organization.

Strategic Relevance

“The challenges of microbial strain engineering often hindered by restrictive intellectual property and the technical hurdles of scaling bioprocesses, have long impeded the faster development of synthetic biology products. By uniting these companies, we can directly address these challenges head-on, transforming the biomanufacturing landscape with the financial and operational support necessary for growth,” said Alex Berlin, CEO of Pictor Biotech Inc. (d.b.a. SOLARBIOTECH).

Zsolt Popsé, CEO of GPC Bio, added, “With nearly 20 years of experience in designing, engineering, automating, and deploying biomanufacturing equipment, we have delivered world-class facilities for leading biopharmaceutical companies such as Merck, Sanofi, and Millipore-Sigma, as well as major food and beverage companies like Cargill, Groupe Soufflet, and Lesaffre. The integration of GPC Bio with EG and SOLARBIOTECH places us in a unique position to mitigate risk and accelerate growth in the biomanufacturing space.”

Lóránd Szabó, Managing Director of Eleszto Genetika Kft., stated, “Over the past two decades, we have developed hundreds of microbial strains for the production of biopharmaceuticals, nutraceuticals, and cosmeceuticals. By joining forces with Solar Biotech and GPC Bio, we can efficiently transition products from laboratory scale to commercial production, overcoming the typical hurdles faced by non-integrated organizations.”

Peter Rosholm, owner of EG, GPC Bio and Pictor Biotech (dba SOLARBIOTECH) emphasized: “I am fully committed to investing in and to accelerate the commercial development of sustainable biomanufacturing technologies. By combining SOLARBIOTECH, GPC Bio, and EG under one umbrella, we are uniquely positioning our teams to thrive in this rapidly growing sector. We have a strong, client-focused and diverse organization with very experienced management, and this commitment adds significant funding to the existing companies’ infrastructure.”

About the Companies

Executive Management of the three companies will continue to serve in their respective leadership roles. Peter Rosholm will exclusively serve the organization from an owner and investor capacity.

SOLARBIOTECH (“SBC”), based in Norton, VA, USA, offers world-class expertise in microbial and animal and plant cell precision fermentation and downstream processing across various scales. Leveraging 18 acres of industrial park infrastructure in Southwest Virginia, SBC consistently delivers innovative synthetic biology bioprocesses and products for its partners. 

GPC Bio (“GPC”), headquartered in La Rochelle, France, specializes in the design, automation, software control, engineering, and fabrication of biomanufacturing equipment for the biopharmaceutical, food tech, and beverage industries. For nearly two decades, GPC Bio has delivered state-of-the-art systems to some of the biggest names in industrial biotech and biopharma.

Eleszto Genetika Kft. (“EG”), based in Budapest, Hungary, brings nearly two decades of expertise in R&D for advanced industrial microbial strains. EG’s portfolio includes microbial strains from engineered yeasts, bacteria, and filamentous fungi for producing a wide range of biopharmaceuticals, nutraceuticals, and cosmeceuticals, supported by cutting-edge infrastructure in the heart of the European Union.

For Further Information, Please Contact:

Alex Berlin, CEO & CTO, Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), alex@solarbiotech.com, www.solarbiotech.comZsolt Popsé, CEO of GPC Bio, z.popse@gpcbio.com, www.gpcbio.comLóránd Szabó, Managing Director, Eleszto Genetika Kft., lszabo@elesztogenetika.com, www.elesztogenetika.com

View original content:https://www.prnewswire.com/news-releases/pictor-biotech-inc-dba-solarbiotech-gpc-bio-and-eleszto-genetika-announce-strategic-unification-302357893.html

SOURCE Pictor Biotech Inc. (dba SOLARBIOTECH), GPC Bio, and Eleszto Genetika

Continue Reading

Trending